Publish Time: 2025-10-27 Origin: Bioteke, the First Affiliated Hospital of Zhengzhou University
2025-10-27 14:45:50
On the morning of October 22, 2025, a seminar titled “The Effects of GCG/GLP-1 Dual Receptor Agonist Combined with High-Protein Meal Replacement and Probiotics on Weight and Muscle Mass in Overweight and Obese Type 2 Diabetes Patients” was successfully launched at the Department of Endocrinology, the First Affiliated Hospital of Zhengzhou University.
The event was jointly organized by the hospital’s endocrinology department together with Wuxi Bioteke and Xijian Health. It aimed to explore an integrated approach for improving weight management and metabolic balance among patients with type 2 diabetes.
During the discussion, both clinical and research teams exchanged insights on one of the most critical challenges in diabetes management — “easy to lose weight, difficult to preserve muscle.”
Experts from the hospital shared their clinical experiences on GLP-1 receptor agonists in controlling blood glucose and body weight, while Bioteke and Xijian Health introduced their latest findings on high-protein meal replacement and probiotic supplementation for maintaining muscle mass and enhancing metabolic health.
This collaboration marks a new step in bridging clinical practice and life science innovation. By integrating pharmacological, nutritional, and microbiome-based approaches, both sides are working toward a more precise and sustainable model for chronic disease management.
Bioteke and Xijian Health will continue to deepen cooperation with medical institutions to advance research in clinical nutrition and metabolic intervention — bringing scientific and compassionate care to people living with chronic diseases.
— END —
Note:
Wuxi Xijian Health Management Co., Ltd.
Wuxi Xijian Health Management Co., Ltd. was established as a wholly owned subsidiary of BioTeke Corporation(Wuxi) Co., Ltd.
Core Focus
The company is dedicated to the health and wellness industry, covering key areas such as sub-health monitoring, chronic disease management, weight and metabolic health, gut microbiota balance, immune system enhancement, and skin rejuvenation.
Business and Expertise
Comprehensive Health Systems: Xijian has developed an integrated “Six (or Eight) Dimensions of Health System,” which includes programs for metabolic syndrome management (hypertension, hyperlipidemia, hyperglycemia), gut microbiome regulation, weight control, immune enhancement, cell therapy, and anti-aging care.
Sub-Health Risk Monitoring: The company has introduced a Sub-Health Screening and Risk Monitoring System, enabling early detection, prevention, and personalized intervention.
Technology-Driven Nutrition and Care: Leveraging Bioteke’s expertise in life sciences, molecular diagnostics, and laboratory instrumentation, Xijian Health integrates “Detection – Intervention – Management” into its service model, bridging clinical testing with daily health management.
Vision and Mission
Xijian Health aims to drive transformation within the health industry — shifting from passive treatment to active prevention and holistic health management.
Through professional services, data-driven monitoring, and evidence-based nutritional interventions, the company seeks to provide systematic and personalized health solutions for individuals with sub-health conditions and those at high risk of chronic diseases.